Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest Expense - DebtInterest Expense - DepositsInterest ExpensesInterest Income - Debt SecuritiesInterest Income - DepositsInterest Income - NetInterest Income - TotalInterest income - LoansInvestment Banking IncomeInvestment Gain (Loss)Net Income towards Common StockholdersNon-Interest IncomeOperating ExpensesOther Non-Interest IncomeOther Operating ExpensesPension (IS)Profit After TaxProvisionsRent ExpenseResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Chemung Financial (CHMG) EBITDA (2016 - 2025)

Historic EBITDA for Chemung Financial (CHMG) over the last 10 years, with Q3 2025 value amounting to $21.7 million.

  • Chemung Financial's EBITDA rose 24.53% to $21.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $66.2 million, marking a year-over-year decrease of 1903.6%. This contributed to the annual value of $85.2 million for FY2024, which is 26053.82% up from last year.
  • Chemung Financial's EBITDA amounted to $21.7 million in Q3 2025, which was up 24.53% from $3.9 million recorded in Q2 2025.
  • Over the past 5 years, Chemung Financial's EBITDA peaked at $22.6 million during Q1 2024, and registered a low of -$13.3 million during Q4 2022.
  • For the 5-year period, Chemung Financial's EBITDA averaged around $2.7 million, with its median value being -$10.5 million (2021).
  • Per our database at Business Quant, Chemung Financial's EBITDA surged by 27930.18% in 2023 and then crashed by 8092.0% in 2025.
  • Chemung Financial's EBITDA (Quarter) stood at -$11.4 million in 2021, then fell by 16.9% to -$13.3 million in 2022, then surged by 229.79% to $17.3 million in 2023, then increased by 20.07% to $20.7 million in 2024, then rose by 4.44% to $21.7 million in 2025.
  • Its EBITDA was $21.7 million in Q3 2025, compared to $3.9 million in Q2 2025 and $19.9 million in Q1 2025.